Methylation of TMEM176A, a key ERK signaling regulator, is a novel synthetic lethality marker of ATM inhibitors in human lung cancer.
Li H, Yang W, Zhang M, He T, Zhou F, G Herman J, Hu L, Guo M. Epigenomics. 2021 Sep; 13(17):1403-1419. Epub 2021 Sep 24.